Asthma management in low and middle income countries: case for change
Top Cited Papers
Open Access
- 15 September 2022
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 60 (3) , 2103179
Abstract
Asthma is the most common noncommunicable disease in children, and among the most common in adults. The great majority of people with asthma live in low and middle income countries (LMICs), which have disproportionately high asthma-related morbidity and mortality. Essential inhaled medications, particularly those containing inhaled corticosteroids (ICS), are often unavailable or unaffordable, and this explains much of the global burden of preventable asthma morbidity and mortality. Guidelines developed for LMICs are generally based on the outdated assumption that patients with asthma symptoms 2 -agonists (SABA) alone, owing to issues of availability and affordability. A single ICS–formoterol inhaler-based approach to asthma management for all severities of asthma, from mild to severe, starting at diagnosis, might overcome SABA overuse/over-reliance and reduce the burden of symptoms and severe exacerbations. However, ICS–formoterol inhalers are currently very poorly available or unaffordable in LMICs. There is a pressing need for pragmatic clinical trial evidence of the feasibility and cost-effectiveness of this and other strategies to improve asthma care in these countries. The global health inequality in asthma care that deprives so many children, adolescents and adults of healthy lives and puts them at increased risk of death, despite the availability of highly effective therapeutic approaches, is unacceptable. A World Health Assembly Resolution on universal access to affordable and effective asthma care is needed to focus attention and investment on addressing this need.Keywords
This publication has 118 references indexed in Scilit:
- Residential Dampness and Molds and the Risk of Developing Asthma: A Systematic Review and Meta-AnalysisPLOS ONE, 2012
- Socioeconomic Inequality in Smoking in Low-Income and Middle-Income Countries: Results from the World Health SurveyPLOS ONE, 2012
- Prenatal and Passive Smoke Exposure and Incidence of Asthma and Wheeze: Systematic Review and Meta-analysisPediatrics, 2012
- The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapyRespiratory Research, 2012
- Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment stepsRespiratory Research, 2011
- House dust mite sensitization in toddlers predicts current wheeze at age 12 yearsJournal of Allergy and Clinical Immunology, 2011
- The Impact of a Program for Control of Asthma in a Low-Income SettingWorld Allergy Organization Journal, 2010
- Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?British Journal of General Practice, 2008
- Rescue Use of Beclomethasone and Albuterol in a Single Inhaler for Mild AsthmaNew England Journal of Medicine, 2007
- Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthmaThorax, 2002